A Maryland board’s decision to establish price limits on
Maryland’s Prescription Drug Affordability Board is moving to become the second-such entity to set an upper price limit for what state and local government health plans pay for a prescription drug. Setting UPLs, as they’re known, is a controversial authority possessed by only a few state PDABs. Colorado used the power in 2025 over the biologic Enbrel and was swiftly met with litigation from drugmaker